Summary
The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market size (value , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- These countries contributed $2,44,334.3 million to the global pharmaceuticals industry in 2024, with a compound annual growth rate (CAGR) of 6% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $3,24,264.0 million in 2029, with a CAGR of 5.8% over the 2024-29 period.
- Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $1,56,589.1 million in 2024. This was followed by India and Brazil with a value of $40,265.1 and $27,129.2 million, respectively.
- China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $2,09,908.0 million in 2029, followed by India and Brazil with expected values of $53,016.9 and $34,928.5 million, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the emerging five pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
- Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to Buy
- What was the size of the emerging five pharmaceuticals market by value in 2024?
- What will be the size of the emerging five pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up the emerging five pharmaceuticals market?
'
Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Pharmaceuticals in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. Johnson & Johnson
13.2. Merck & Co Inc
13.3. AbbVie Inc
13.4. Pfizer Inc
13.5. Sinopharm Group Co Ltd
13.6. Shanghai Pharmaceuticals Holding Co Ltd
13.7. CSPC Pharmaceutical Group Ltd
13.8. Takeda Pharmaceutical Co Ltd
13.9. Novartis AG
13.10. AstraZeneca Plc
13.11. GSK plc
13.12. F. Hoffmann-La Roche Ltd
13.13. Sanofi
13.14. Laboratoires Pierre Fabre SA
13.15. Les Laboratoires Servier SAS
13.16. Ipsen SA
13.17. Bayer AG
13.18. Boehringer Ingelheim International GmbH
13.19. Fresenius Medical Care AG & Co KGaA
13.20. Merck KGaA
13.21. CSL Ltd
13.22. Ramsay Health Care Ltd
13.23. Mayne Pharma Group Ltd
13.24. Ache Laboratorios Farmaceuticos SA
13.25. EMS SA
13.26. Hypera SA
13.27. Eurofarma Laboratorios SA
13.28. Apotex Inc
13.29. Bausch Health Companies Inc
13.30. Jiangsu Hengrui Pharmaceuticals Co Ltd
13.31. Sun Pharmaceutical Industries Ltd
13.32. Lupin Ltd
13.33. Cipla Ltd
13.34. Dr. Reddy's Laboratories Ltd
13.35. PT Kimia Farma Tbk
13.36. PT Kalbe Farma Tbk
13.37. PT Tempo Scan Pacific Tbk
13.38. A. Menarini Industrie Farmaceutiche Riunite Srl
13.39. Recordati SpA
13.40. Chiesi Farmaceutici SpA
13.41. Astellas Pharma Inc
13.42. Daiichi Sankyo Co Ltd
13.43. Otsuka Holdings Co Ltd
13.44. Genomma Lab Internacional SAB de CV
13.45. Pharmstandard
13.46. Binnopharm Group
13.47. OTC Pharma International BV
13.48. H. Lundbeck AS
13.49. Novo Nordisk AS
13.50. Aspen Pharmacare Holdings Ltd
13.51. Adcock Ingram Holdings Ltd
13.52. Chong Kun Dang Pharmaceutical Corp.
13.53. Hanmi Pharmaceuticals Co Ltd
13.54. Celltrion Inc
13.55. Yuhan Corp
13.56. Almirall SAS
13.57. Grifols SA
13.58. Laboratorios Farmaceuticos Rovi SA
13.59. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
13.60. Deva Holding AS
14 Appendix
14.1. Methodology
14.2. About MarketLine
List of Tables
Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($m), 2020-29
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($m), 2020-24
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($m), 2024-29
Table 4: South Africa pharmaceuticals market value: $ million, 2019-24
Table 5: South Africa pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 6: South Africa pharmaceuticals market category segmentation: $ million, 2019-24
Table 7: South Africa pharmaceuticals market geography segmentation: $ million, 2024
Table 8: South Africa pharmaceuticals market value forecast: $ million, 2024-29
Table 9: South Africa Size of Population (Million), 2020-24
Table 10: South Africa Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 11: South Africa GDP (Current Prices, $ Billion), 2020-24
Table 12: South Africa Inflation, 2020-24
Table 13: South Africa Consumer Price Index (Absolute), 2020-24
Table 14: South Africa Exchange Rate, 2019-24
Table 15: Brazil pharmaceuticals market value: $ million, 2019-24
Table 16: Brazil pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 17: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Table 18: Brazil pharmaceuticals market geography segmentation: $ million, 2024
Table 19: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Table 20: Brazil Size of Population (Million), 2020-24
Table 21: Brazil Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 22: Brazil GDP (Current Prices, $ Billion), 2020-24
Table 23: Brazil Inflation, 2020-24
Table 24: Brazil Consumer Price Index (Absolute), 2020-24
Table 25: Brazil Exchange Rate, 2019-24
Table 26: China pharmaceuticals market value: $ million, 2019-24
Table 27: China pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 28: China pharmaceuticals market category segmentation: $ million, 2019-24
Table 29: China pharmaceuticals market geography segmentation: $ million, 2024
Table 30: China pharmaceuticals market value forecast: $ million, 2024-29
Table 31: China Size of Population (Million), 2020-24
Table 32: China Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 33: China GDP (Current Prices, $ Billion), 2020-24
Table 34: China Inflation, 2020-24
Table 35: China Consumer Price Index (Absolute), 2020-24
Table 36: China Exchange Rate, 2019-24
Table 37: India pharmaceuticals market value: $ million, 2019-24
Table 38: India pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 39: India pharmaceuticals market category segmentation: $ million, 2019-24
Table 40: India pharmaceuticals market geography segmentation: $ million, 2024
Table 41: India pharmaceuticals market value forecast: $ million, 2024-29
Table 42: India Size of Population (Million), 2020-24
Table 43: India Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 44: India GDP (Current Prices, $ Billion), 2020-24
Table 45: India Inflation, 2020-24
Table 46: India Consumer Price Index (Absolute), 2020-24
Table 47: India Exchange Rate, 2019-24
Table 48: Mexico pharmaceuticals market value: $ million, 2019-24
Table 49: Mexico pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 50: Mexico pharmaceuticals market category segmentation: $ million, 2019-24
Table 51: Mexico pharmaceuticals market geography segmentation: $ million, 2024
Table 52: Mexico pharmaceuticals market value forecast: $ million, 2024-29
Table 53: Mexico Size of Population (Million), 2020-24
Table 54: Mexico Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 55: Mexico GDP (Current Prices, $ Billion), 2020-24
Table 56: Mexico Inflation, 2020-24
Table 57: Mexico Consumer Price Index (Absolute), 2020-24
Table 58: Mexico Exchange Rate, 2019-24
List of Figures
Figure 1: Top 5 emerging countries pharmaceuticals industry, revenue ($m), 2020-29
Figure 2: Top 5 emerging countries pharmaceuticals industry, revenue ($m), 2020-24
Figure 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($m), 2024-29
Figure 4: South Africa pharmaceuticals market value: $ million, 2019-24
Figure 5: South Africa pharmaceuticals market category segmentation: $ million, 2019-24
Figure 6: South Africa pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 7: South Africa pharmaceuticals market value forecast: $ million, 2024-29
Figure 8: Forces driving competition in the pharmaceuticals market in South Africa, 2024
Figure 9: Drivers of buyer power in the pharmaceuticals market in South Africa, 2024
Figure 10: Drivers of supplier power in the pharmaceuticals market in South Africa, 2024
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2024
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2024
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2024
Figure 14: Brazil pharmaceuticals market value: $ million, 2019-24
Figure 15: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Figure 16: Brazil pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 17: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Figure 18: Forces driving competition in the pharmaceuticals market in Brazil, 2024
Figure 19: Drivers of buyer power in the pharmaceuticals market in Brazil, 2024
Figure 20: Drivers of supplier power in the pharmaceuticals market in Brazil, 2024
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2024
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2024
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2024
Figure 24: China pharmaceuticals market value: $ million, 2019-24
Figure 25: China pharmaceuticals market category segmentation: $ million, 2019-24
Figure 26: China pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 27: China pharmaceuticals market value forecast: $ million, 2024-29
Figure 28: Forces driving competition in the pharmaceuticals market in China, 2024
Figure 29: Drivers of buyer power in the pharmaceuticals market in China, 2024
Figure 30: Drivers of supplier power in the pharmaceuticals market in China, 2024
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2024
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2024
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in China, 2024
Figure 34: India pharmaceuticals market value: $ million, 2019-24
Figure 35: India pharmaceuticals market category segmentation: $ million, 2019-24
Figure 36: India pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 37: India pharmaceuticals market value forecast: $ million, 2024-29
Figure 38: Forces driving competition in the pharmaceuticals market in India, 2024
Figure 39: Drivers of buyer power in the pharmaceuticals market in India, 2024
Figure 40: Drivers of supplier power in the pharmaceuticals market in India, 2024
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2024
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2024
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in India, 2024
Figure 44: Mexico pharmaceuticals market value: $ million, 2019-24
Figure 45: Mexico pharmaceuticals market category segmentation: $ million, 2019-24
Figure 46: Mexico pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 47: Mexico pharmaceuticals market value forecast: $ million, 2024-29
Figure 48: Forces driving competition in the pharmaceuticals market in Mexico, 2024
Figure 49: Drivers of buyer power in the pharmaceuticals market in Mexico, 2024
Figure 50: Drivers of supplier power in the pharmaceuticals market in Mexico, 2024
Figure 51: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2024
Figure 52: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2024
Figure 53: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2024
